Initial antigen encounter programs CD8+ T cells competent to develop into memory cells that are activated in an antigen-free, IL-7- and IL-15-rich environment

被引:83
作者
Carrio, R
Bathe, OF
Malek, TR
机构
[1] Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA
[2] Univ Calgary, Dept Surg, Calgary, AB, Canada
[3] Univ Calgary, Dept Oncol, Tom Baker Canc Ctr, Calgary, AB, Canada
关键词
D O I
10.4049/jimmunol.172.12.7315
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although much is known concerning the immunobiology of CD8(+) T memory cells, the initial events favoring the generation of CD8(+) T memory cells remain poorly defined. Using a culture system that yields memory-like CD8(+) T cells, we show that 1 day after Ag encounter, Ag-activated T cells developed into memory-like T cells, but this optimally occurred 3 days after Ag encounter. Key phenotypic, functional, and molecular properties that typify central memory T cells were expressed within 48 h when the activated CD8(+) T cells were cultured with IL-7 or IL-15 in the absence of Ag or following transfer into normal mice. These data support a model whereby Ag activation of naive CD8(+) T cells not only programs effector cell expansion and contraction but the potential to develop into a memory cell which ensues in an Ag-free environment containing IL-7 or IL-15.
引用
收藏
页码:7315 / 7323
页数:9
相关论文
共 52 条
[1]   Immunological memory and protective immunity: Understanding their relation [J].
Ahmed, R ;
Gray, D .
SCIENCE, 1996, 272 (5258) :54-60
[2]   Programmed contraction of CD8+ T cells after infection [J].
Badovinac, VP ;
Porter, BB ;
Harty, JT .
NATURE IMMUNOLOGY, 2002, 3 (07) :619-626
[3]   IL-2 during in vitro priming promotes subsequent engraftment and successful adoptive tumor immunotherapy by persistent memory phenotypic CD8+ T cells [J].
Bathe, OF ;
Dalyot-Herman, N ;
Malek, TR .
JOURNAL OF IMMUNOLOGY, 2001, 167 (08) :4511-4517
[4]  
Beckett S, 2002, CALL CENT MAG, V15, P8
[5]   TNF-Mediated toxicity after massive induction of specific CD8+ T cells following immunization of mice with a tumor-specific peptide [J].
Bilsborough, J ;
Uyttenhove, C ;
Colau, D ;
Bousso, P ;
Libert, C ;
Weynand, B ;
Boon, T ;
Van den Eynde, BJ .
JOURNAL OF IMMUNOLOGY, 2002, 169 (06) :3053-3060
[6]   4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy [J].
Cannons, JL ;
Lau, P ;
Ghumman, B ;
DeBenedette, MA ;
Yagita, H ;
Okumura, K ;
Watts, TH .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1313-1324
[7]   Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection [J].
Clarke, SRM ;
Barnden, M ;
Kurts, C ;
Carbone, FR ;
Miller, JF ;
Heath, WR .
IMMUNOLOGY AND CELL BIOLOGY, 2000, 78 (02) :110-117
[8]   Quantitation of phosphotyrosine signals in human prostate cell adhesion sites [J].
Cress, AE .
BIOTECHNIQUES, 2000, 29 (04) :776-+
[9]  
Curtsinger JM, 1998, J IMMUNOL, V160, P3236
[10]   Reversal of CD8+ T cell ignorance and induction of anti-tumor immunity by peptide-pulsed APC [J].
Dalyot-Herman, N ;
Bathe, OF ;
Malek, TR .
JOURNAL OF IMMUNOLOGY, 2000, 165 (12) :6731-6737